Global RNA Analysis /Transcriptomic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 183170
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Consumer Goods
Buy @ $3500

The RNA Analysis /Transcriptomic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global RNA Analysis /Transcriptomic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global RNA Analysis /Transcriptomic market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

RNA Analysis /Transcriptomic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Microarrays

Sequencing

Polymerase Chain Reaction

RNA Interference

Market segment by Application, can be divided into

Clinical Diagnostics

Drug Discovery

Toxicogenomics

Comparative Transcriptomics

Market segment by players, this report covers

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Merck KGaA

Agilent Technologies, Inc.

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Fluidigm Corporation

Eurofins Scientific

Sequentia Biotech SL

Acobiom

GenXPro GmbH

CD Genomics

Promega Corporation

Cenix BioScience GmbH

Takara Holdings, Inc.

bioMérieux SA

LC Sciences LLC

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of RNA Analysis /Transcriptomic

1.2 Classification of RNA Analysis /Transcriptomic by Type

1.2.1 Overview: Global RNA Analysis /Transcriptomic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global RNA Analysis /Transcriptomic Revenue Market Share by Type in 2020

1.2.3 Microarrays

1.2.4 Sequencing

1.2.5 Polymerase Chain Reaction

1.2.6 RNA Interference

1.3 Global RNA Analysis /Transcriptomic Market by Application

1.3.1 Overview: Global RNA Analysis /Transcriptomic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Clinical Diagnostics

1.3.3 Drug Discovery

1.3.4 Toxicogenomics

1.3.5 Comparative Transcriptomics

1.4 Global RNA Analysis /Transcriptomic Market Size & Forecast

1.5 Global RNA Analysis /Transcriptomic Market Size and Forecast by Region

1.5.1 Global RNA Analysis /Transcriptomic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global RNA Analysis /Transcriptomic Market Size by Region, (2016-2021)

1.5.3 North America RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)

1.5.4 Europe RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)

1.5.6 South America RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 RNA Analysis /Transcriptomic Market Drivers

1.6.2 RNA Analysis /Transcriptomic Market Restraints

1.6.3 RNA Analysis /Transcriptomic Trends Analysis

2 Company Profiles

2.1 Thermo Fisher Scientific, Inc.

2.1.1 Thermo Fisher Scientific, Inc. Details

2.1.2 Thermo Fisher Scientific, Inc. Major Business

2.1.3 Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Product and Solutions

2.1.4 Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

2.2 Bio-Rad Laboratories, Inc.

2.2.1 Bio-Rad Laboratories, Inc. Details

2.2.2 Bio-Rad Laboratories, Inc. Major Business

2.2.3 Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Product and Solutions

2.2.4 Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

2.3 Merck KGaA

2.3.1 Merck KGaA Details

2.3.2 Merck KGaA Major Business

2.3.3 Merck KGaA RNA Analysis /Transcriptomic Product and Solutions

2.3.4 Merck KGaA RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Merck KGaA Recent Developments and Future Plans

2.4 Agilent Technologies, Inc.

2.4.1 Agilent Technologies, Inc. Details

2.4.2 Agilent Technologies, Inc. Major Business

2.4.3 Agilent Technologies, Inc. RNA Analysis /Transcriptomic Product and Solutions

2.4.4 Agilent Technologies, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Agilent Technologies, Inc. Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche Ltd.

2.5.1 F. Hoffmann-La Roche Ltd. Details

2.5.2 F. Hoffmann-La Roche Ltd. Major Business

2.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Product and Solutions

2.5.4 F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

2.6 Danaher Corporation

2.6.1 Danaher Corporation Details

2.6.2 Danaher Corporation Major Business

2.6.3 Danaher Corporation RNA Analysis /Transcriptomic Product and Solutions

2.6.4 Danaher Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Danaher Corporation Recent Developments and Future Plans

2.7 Fluidigm Corporation

2.7.1 Fluidigm Corporation Details

2.7.2 Fluidigm Corporation Major Business

2.7.3 Fluidigm Corporation RNA Analysis /Transcriptomic Product and Solutions

2.7.4 Fluidigm Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Fluidigm Corporation Recent Developments and Future Plans

2.8 Eurofins Scientific

2.8.1 Eurofins Scientific Details

2.8.2 Eurofins Scientific Major Business

2.8.3 Eurofins Scientific RNA Analysis /Transcriptomic Product and Solutions

2.8.4 Eurofins Scientific RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Eurofins Scientific Recent Developments and Future Plans

2.9 Sequentia Biotech SL

2.9.1 Sequentia Biotech SL Details

2.9.2 Sequentia Biotech SL Major Business

2.9.3 Sequentia Biotech SL RNA Analysis /Transcriptomic Product and Solutions

2.9.4 Sequentia Biotech SL RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Sequentia Biotech SL Recent Developments and Future Plans

2.10 Acobiom

2.10.1 Acobiom Details

2.10.2 Acobiom Major Business

2.10.3 Acobiom RNA Analysis /Transcriptomic Product and Solutions

2.10.4 Acobiom RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Acobiom Recent Developments and Future Plans

2.11 GenXPro GmbH

2.11.1 GenXPro GmbH Details

2.11.2 GenXPro GmbH Major Business

2.11.3 GenXPro GmbH RNA Analysis /Transcriptomic Product and Solutions

2.11.4 GenXPro GmbH RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 GenXPro GmbH Recent Developments and Future Plans

2.12 CD Genomics

2.12.1 CD Genomics Details

2.12.2 CD Genomics Major Business

2.12.3 CD Genomics RNA Analysis /Transcriptomic Product and Solutions

2.12.4 CD Genomics RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 CD Genomics Recent Developments and Future Plans

2.13 Promega Corporation

2.13.1 Promega Corporation Details

2.13.2 Promega Corporation Major Business

2.13.3 Promega Corporation RNA Analysis /Transcriptomic Product and Solutions

2.13.4 Promega Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Promega Corporation Recent Developments and Future Plans

2.14 Cenix BioScience GmbH

2.14.1 Cenix BioScience GmbH Details

2.14.2 Cenix BioScience GmbH Major Business

2.14.3 Cenix BioScience GmbH RNA Analysis /Transcriptomic Product and Solutions

2.14.4 Cenix BioScience GmbH RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Cenix BioScience GmbH Recent Developments and Future Plans

2.15 Takara Holdings, Inc.

2.15.1 Takara Holdings, Inc. Details

2.15.2 Takara Holdings, Inc. Major Business

2.15.3 Takara Holdings, Inc. RNA Analysis /Transcriptomic Product and Solutions

2.15.4 Takara Holdings, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Takara Holdings, Inc. Recent Developments and Future Plans

2.16 bioMérieux SA

2.16.1 bioMérieux SA Details

2.16.2 bioMérieux SA Major Business

2.16.3 bioMérieux SA RNA Analysis /Transcriptomic Product and Solutions

2.16.4 bioMérieux SA RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 bioMérieux SA Recent Developments and Future Plans

2.17 LC Sciences LLC

2.17.1 LC Sciences LLC Details

2.17.2 LC Sciences LLC Major Business

2.17.3 LC Sciences LLC RNA Analysis /Transcriptomic Product and Solutions

2.17.4 LC Sciences LLC RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 LC Sciences LLC Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global RNA Analysis /Transcriptomic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 RNA Analysis /Transcriptomic Players Market Share

3.2.2 Top 10 RNA Analysis /Transcriptomic Players Market Share

3.2.3 Market Competition Trend

3.3 RNA Analysis /Transcriptomic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global RNA Analysis /Transcriptomic Revenue and Market Share by Type (2016-2021)

4.2 Global RNA Analysis /Transcriptomic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global RNA Analysis /Transcriptomic Revenue Market Share by Application (2016-2021)

5.2 RNA Analysis /Transcriptomic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America RNA Analysis /Transcriptomic Revenue by Type (2016-2026)

6.2 North America RNA Analysis /Transcriptomic Revenue by Application (2016-2026)

6.3 North America RNA Analysis /Transcriptomic Market Size by Country

6.3.1 North America RNA Analysis /Transcriptomic Revenue by Country (2016-2026)

6.3.2 United States RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

6.3.3 Canada RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

6.3.4 Mexico RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe RNA Analysis /Transcriptomic Revenue by Type (2016-2026)

7.2 Europe RNA Analysis /Transcriptomic Revenue by Application (2016-2026)

7.3 Europe RNA Analysis /Transcriptomic Market Size by Country

7.3.1 Europe RNA Analysis /Transcriptomic Revenue by Country (2016-2026)

7.3.2 Germany RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

7.3.3 France RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

7.3.5 Russia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

7.3.6 Italy RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2016-2026)

8.2 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2016-2026)

8.3 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region

8.3.1 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2016-2026)

8.3.2 China RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8.3.3 Japan RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8.3.4 South Korea RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8.3.5 India RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

8.3.7 Australia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America RNA Analysis /Transcriptomic Revenue by Type (2016-2026)

9.2 South America RNA Analysis /Transcriptomic Revenue by Application (2016-2026)

9.3 South America RNA Analysis /Transcriptomic Market Size by Country

9.3.1 South America RNA Analysis /Transcriptomic Revenue by Country (2016-2026)

9.3.2 Brazil RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

9.3.3 Argentina RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2016-2026)

10.2 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2016-2026)

10.3 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country

10.3.1 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2016-2026)

10.3.2 Turkey RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

10.3.4 UAE RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global RNA Analysis /Transcriptomic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global RNA Analysis /Transcriptomic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market RNA Analysis /Transcriptomic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Region (2016-2021)

Table 5. Global RNA Analysis /Transcriptomic Revenue Market Share by Region (2021-2026)

Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific, Inc. Major Business

Table 8. Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Product and Solutions

Table 9. Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Bio-Rad Laboratories, Inc. Major Business

Table 12. Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Product and Solutions

Table 13. Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 15. Merck KGaA Major Business

Table 16. Merck KGaA RNA Analysis /Transcriptomic Product and Solutions

Table 17. Merck KGaA RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Agilent Technologies, Inc. Major Business

Table 20. Agilent Technologies, Inc. RNA Analysis /Transcriptomic Product and Solutions

Table 21. Agilent Technologies, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Ltd. Major Business

Table 24. F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Product and Solutions

Table 25. F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Danaher Corporation Major Business

Table 28. Danaher Corporation RNA Analysis /Transcriptomic Product and Solutions

Table 29. Danaher Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Fluidigm Corporation Corporate Information, Head Office, and Major Competitors

Table 31. Fluidigm Corporation Major Business

Table 32. Fluidigm Corporation RNA Analysis /Transcriptomic Product and Solutions

Table 33. Fluidigm Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Eurofins Scientific Corporate Information, Head Office, and Major Competitors

Table 35. Eurofins Scientific Major Business

Table 36. Eurofins Scientific RNA Analysis /Transcriptomic Product and Solutions

Table 37. Eurofins Scientific RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Sequentia Biotech SL Corporate Information, Head Office, and Major Competitors

Table 39. Sequentia Biotech SL Major Business

Table 40. Sequentia Biotech SL RNA Analysis /Transcriptomic Product and Solutions

Table 41. Sequentia Biotech SL RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Acobiom Corporate Information, Head Office, and Major Competitors

Table 43. Acobiom Major Business

Table 44. Acobiom RNA Analysis /Transcriptomic Product and Solutions

Table 45. Acobiom RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. GenXPro GmbH Corporate Information, Head Office, and Major Competitors

Table 47. GenXPro GmbH Major Business

Table 48. GenXPro GmbH RNA Analysis /Transcriptomic Product and Solutions

Table 49. GenXPro GmbH RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. CD Genomics Corporate Information, Head Office, and Major Competitors

Table 51. CD Genomics Major Business

Table 52. CD Genomics RNA Analysis /Transcriptomic Product and Solutions

Table 53. CD Genomics RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Promega Corporation Corporate Information, Head Office, and Major Competitors

Table 55. Promega Corporation Major Business

Table 56. Promega Corporation RNA Analysis /Transcriptomic Product and Solutions

Table 57. Promega Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Cenix BioScience GmbH Corporate Information, Head Office, and Major Competitors

Table 59. Cenix BioScience GmbH Major Business

Table 60. Cenix BioScience GmbH RNA Analysis /Transcriptomic Product and Solutions

Table 61. Cenix BioScience GmbH RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Takara Holdings, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Takara Holdings, Inc. Major Business

Table 64. Takara Holdings, Inc. RNA Analysis /Transcriptomic Product and Solutions

Table 65. Takara Holdings, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. bioMérieux SA Corporate Information, Head Office, and Major Competitors

Table 67. bioMérieux SA Major Business

Table 68. bioMérieux SA RNA Analysis /Transcriptomic Product and Solutions

Table 69. bioMérieux SA RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. LC Sciences LLC Corporate Information, Head Office, and Major Competitors

Table 71. LC Sciences LLC Major Business

Table 72. LC Sciences LLC RNA Analysis /Transcriptomic Product and Solutions

Table 73. LC Sciences LLC RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Players (2019-2021)

Table 75. Global RNA Analysis /Transcriptomic Revenue Share by Players (2019-2021)

Table 76. Breakdown of RNA Analysis /Transcriptomic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. RNA Analysis /Transcriptomic Players Head Office, Products and Services Provided

Table 78. RNA Analysis /Transcriptomic Mergers & Acquisitions in the Past Five Years

Table 79. RNA Analysis /Transcriptomic New Entrants and Expansion Plans

Table 80. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Type (2016-2021)

Table 81. Global RNA Analysis /Transcriptomic Revenue Share by Type (2016-2021)

Table 82. Global RNA Analysis /Transcriptomic Revenue Forecast by Type (2021-2026)

Table 83. Global RNA Analysis /Transcriptomic Revenue by Application (2016-2021)

Table 84. Global RNA Analysis /Transcriptomic Revenue Forecast by Application (2021-2026)

Table 85. North America RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)

Table 86. North America RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)

Table 87. North America RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)

Table 88. North America RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)

Table 89. North America RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)

Table 90. North America RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2021-2026) & (USD Million)

Table 103. South America RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)

Table 104. South America RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)

Table 105. South America RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)

Table 106. South America RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)

Table 107. South America RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)

Table 108. South America RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. RNA Analysis /Transcriptomic Picture

Figure 2. Global RNA Analysis /Transcriptomic Revenue Market Share by Type in 2020

Figure 3. Microarrays

Figure 4. Sequencing

Figure 5. Polymerase Chain Reaction

Figure 6. RNA Interference

Figure 7. RNA Analysis /Transcriptomic Revenue Market Share by Application in 2020

Figure 8. Clinical Diagnostics Picture

Figure 9. Drug Discovery Picture

Figure 10. Toxicogenomics Picture

Figure 11. Comparative Transcriptomics Picture

Figure 12. Global RNA Analysis /Transcriptomic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global RNA Analysis /Transcriptomic Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global RNA Analysis /Transcriptomic Revenue Market Share by Region (2016-2026)

Figure 15. Global RNA Analysis /Transcriptomic Revenue Market Share by Region in 2020

Figure 16. North America RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. RNA Analysis /Transcriptomic Market Drivers

Figure 22. RNA Analysis /Transcriptomic Market Restraints

Figure 23. RNA Analysis /Transcriptomic Market Trends

Figure 24. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

Figure 25. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

Figure 26. Merck KGaA Recent Developments and Future Plans

Figure 27. Agilent Technologies, Inc. Recent Developments and Future Plans

Figure 28. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

Figure 29. Danaher Corporation Recent Developments and Future Plans

Figure 30. Fluidigm Corporation Recent Developments and Future Plans

Figure 31. Eurofins Scientific Recent Developments and Future Plans

Figure 32. Sequentia Biotech SL Recent Developments and Future Plans

Figure 33. Acobiom Recent Developments and Future Plans

Figure 34. GenXPro GmbH Recent Developments and Future Plans

Figure 35. CD Genomics Recent Developments and Future Plans

Figure 36. Promega Corporation Recent Developments and Future Plans

Figure 37. Cenix BioScience GmbH Recent Developments and Future Plans

Figure 38. Takara Holdings, Inc. Recent Developments and Future Plans

Figure 39. bioMérieux SA Recent Developments and Future Plans

Figure 40. LC Sciences LLC Recent Developments and Future Plans

Figure 41. Global RNA Analysis /Transcriptomic Revenue Share by Players in 2020

Figure 42. RNA Analysis /Transcriptomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players RNA Analysis /Transcriptomic Revenue Market Share in 2020

Figure 44. Global Top 10 Players RNA Analysis /Transcriptomic Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global RNA Analysis /Transcriptomic Revenue Share by Type in 2020

Figure 47. Global RNA Analysis /Transcriptomic Market Share Forecast by Type (2021-2026)

Figure 48. Global RNA Analysis /Transcriptomic Revenue Share by Application in 2020

Figure 49. Global RNA Analysis /Transcriptomic Market Share Forecast by Application (2021-2026)

Figure 50. North America RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)

Figure 51. North America RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)

Figure 52. North America RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)

Figure 53. United States RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)

Figure 57. Europe RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)

Figure 58. Europe RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)

Figure 59. Germany RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific RNA Analysis /Transcriptomic Revenue Market Share by Region (2016-2026)

Figure 67. China RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)

Figure 74. South America RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)

Figure 75. South America RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)

Figure 76. Brazil RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)

Figure 81. Turkey RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source